The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy of long-term treatment for > 5-10 years with the LHRH analog leuprorelin acetate in patients with prostate ancer: Results from a noninterventional study.
Peter Hammerer
Honoraria - Takeda Pharma Vertrieb GmbHCo KG
Manfred Wirth
No relevant relationships to disclose